
南京醫藥:白雲山擬受讓11.04%公司股份南京醫藥晚間公告,公司與廣州白雲山醫藥集團股份有限公司及廣州廣藥
經公司自查,公司目前生產經營活動正常,生產成本和銷售情況未出現大幅波動。2021年新
Read More
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.

There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.